GlassScriptPhysician profile
Brent K Cole
NPI 1558336321
$1,282.39
in general payments reported to CMS, 2019-2025
24 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $189 · 2023: $30.50 · 2024: $37.24 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $124.19 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Abbvie INC. | $113.84 | 2019 | |
| Celgene Corporation | $110.16 | 2019 | |
| Pfizer INC. | $105.16 | 2019-2020 | |
| Daiichi Sankyo INC. | $95.96 | 2019-2020 | |
| Amarin Pharma, INC. | $94.13 | 2019-2020 | |
| Amgen INC. | $82.34 | 2019-2020 | |
| Inspire Medical Systems, INC. | $82.04 | 2024-2025 | Inspire |
| Abbott Laboratories | $69.57 | 2019 | |
| Novo Nordisk INC | $65.78 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $59.36 | 2019-2025 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.91 | 2019 | |
| Aerin Medical INC. | $27.43 | 2025 | |
| Allergan, INC. | $27.23 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $25.23 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $24.14 | 2019 | |
| Lilly USA, LLC | $23.50 | 2025 | Mounjaro |
| Esperion Therapeutics, INC. | $18.86 | 2025 | Nexletol |
| Amag Pharmaceuticals, INC. | $15.56 | 2019 | |
| Endo Pharmaceuticals INC. | $14.73 | 2020 | |
| Sanofi Pasteur INC. | $14.63 | 2019 | |
| Tactile Systems Technology INC | $13.93 | 2019 | |
| Becton, Dickinson and Company | $12.72 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.